Absence of trypsinogen autoactivation and immunolocalization of pancreatic secretory trypsin inhibitor in acinar cells in vitro.
To establish the significance of the addition of trypsin inhibitors to pancreatic acinar cells maintained in vitro, cells were cultured in the presence or absence of soybean trypsin inhibitor. Both cultures exhibited similar growth pattern, ultrastructural appearance, as well as secretory properties. Moreover, there was no evidence of trypsinogen activation in the culture medium. Using the immunocytochemical approach, pancreatic secretory trypsin inhibitor antigenic sites were revealed with specific polyclonal and monoclonal antibodies. The results obtained demonstrated that this trypsin inhibitor is in fact a typical pancreatic secretory protein being processed through the endoplasmic reticulum-Golgi-granule secretory pathway of the acinar cells in rat and human tissues. While the polyclonal antibody yield labelings of increasing intensities along the secretory pathway, the monoclonal one probably due to the molecular nature of its specific antigenic determinant, gave higher labelings in the endoplasmic reticulum. In conclusion the present study has shown that pancreatic acinar cells secrete a specific pancreatic trypsin inhibitor which most probably is involved in the mechanism to prevent trypsinogen activation.
Arias
A E
AE
Department of Anatomy, Faculty of Medicine, Université de Montréal, Quebec, Canada.
Böldicke
T
T
Bendayan
M
M
D000818:Animals; D003594:Cytoplasmic Granules / Q000737:chemistry; D004721:Endoplasmic Reticulum / Q000737:chemistry; D004789:Enzyme Activation / Q000187:drug effects; D007150:Immunohistochemistry; D010179:Pancreas / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D014361:Trypsin Inhibitors / Q000032:analysis / Q000378:metabolism*; D014362:Trypsinogen / Q000378:metabolism*; D014617:Vacuoles / Q000737:chemistry
D014361:Trypsin Inhibitors; D014362:Trypsinogen